Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Search Results (195)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Heritability of hematologic malignancies: from pedigrees to genomics.Academic Article Why?
Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice.Academic Article Why?
BRCA2 mutation and the risk of hematologic malignancy.Academic Article Why?
Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy.Academic Article Why?
De Novo Development of Bronchiectasis in Patients With Hematologic Malignancy.Academic Article Why?
Delays in referral and diagnosis for chronic hematologic malignancies: a literature review.Academic Article Why?
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies.Academic Article Why?
Emerging role of the histone deacetylase inhibitor romidepsin in hematologic malignancies.Academic Article Why?
Genetic predisposition to hematologic malignancies: management and surveillance.Academic Article Why?
Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.Academic Article Why?
Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies.Academic Article Why?
Molecular cytogenetic characterization of breakpoints in 19 patients with hematologic malignancies and 12p unbalanced translocations.Academic Article Why?
Overexpression of survivin initiates hematologic malignancies in vivo.Academic Article Why?
Perturbations of 5-hydroxymethylcytosine patterning in hematologic malignancies.Academic Article Why?
Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies.Academic Article Why?
Per Page    Page  of 13last Nextnext
Prev
Search Criteria
  • Hematologic Malignancy
Filter by Type